These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 4551050)

  • 1. Catecholamine metabolism, depressive illness, and drug response.
    Maas JW; Fawcett JA; Dekirmenjian H
    Arch Gen Psychiatry; 1972 Mar; 26(3):252-62. PubMed ID: 4551050
    [No Abstract]   [Full Text] [Related]  

  • 2. MHPG excretion by patients with affective disorders.
    Maas JW; Dekirmenjian H; Fawcett JA
    Int Pharmacopsychiatry; 1974; 9(1):14-26. PubMed ID: 4600126
    [No Abstract]   [Full Text] [Related]  

  • 3. Depression and MHPG excretion. Response to dextroamphetamine and tricyclic antidepressants.
    Fawcett J; Maas JW
    Arch Gen Psychiatry; 1972 Mar; 26(3):246-51. PubMed ID: 5059634
    [No Abstract]   [Full Text] [Related]  

  • 4. Catecholamine metabolism in affective disorders. IV. Preliminary studies of norepinephrine metabolism in depressed patients treated with amitriptyline.
    Schildkraut JJ; Draskoczy PR; Gershon ES; Reich P; Grab EL
    J Psychiatr Res; 1972 Sep; 9(3):173-85. PubMed ID: 5083173
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical and biochemical heterogeneity of depressive disorders.
    Maas JW
    Ann Intern Med; 1978 Apr; 88(4):556-63. PubMed ID: 25035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affective disorders and norepinephrine pharmacology.
    Schildkraut JJ; Schanberg SM; Kopin IJ; Durell J
    Int Psychiatry Clin; 1969; 6(2):83-141. PubMed ID: 4897536
    [No Abstract]   [Full Text] [Related]  

  • 7. Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and predicting responses to treatment: preliminary findings.
    Schildkraut JJ
    Am J Psychiatry; 1973 Jun; 130(6):695-9. PubMed ID: 4701961
    [No Abstract]   [Full Text] [Related]  

  • 8. Thyroid-imipramine clinical and chemical interaction: evidence for a receptor deficit in depression.
    Prange AJ; Wilson IC; Knox AE; McClane TK; Breese GR; Martin BR; Alltop LB; Lipton MA
    J Psychiatr Res; 1972 Sep; 9(3):187-205. PubMed ID: 5083174
    [No Abstract]   [Full Text] [Related]  

  • 9. Catecholamine metabolism, depression and stress.
    Maas JW; Dekirmenjian H; Fawcett J
    Nature; 1971 Apr; 230(5292):330-1. PubMed ID: 5549410
    [No Abstract]   [Full Text] [Related]  

  • 10. Alteration of norepinephrine metabolism with desipramine and zimelidine in depressed patients.
    Linnoila M; Karoum F; Calil HM; Kopin IJ; Potter WZ
    Arch Gen Psychiatry; 1982 Sep; 39(9):1025-8. PubMed ID: 6214234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High intercorrelations among urinary outputs of norepinephrine and its major metabolites. A replication in depressed patients and controls.
    Roy A; Guthrie S; Karoum F; Pickar D; Linnoila M
    Arch Gen Psychiatry; 1988 Feb; 45(2):158-61. PubMed ID: 3337613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical correlates of affective disorders in children.
    Cytryn L; McKnew DH; Logue M; Desai RB
    Arch Gen Psychiatry; 1974 Nov; 31(5):659-61. PubMed ID: 4613320
    [No Abstract]   [Full Text] [Related]  

  • 13. Catecholamine metabolism in affective disorders. 3. MHPG and other catecholamine metabolites in patients treated with lithium carbonate.
    Greenspan K; Schildkraut JJ; Gordon EK; Baer L; Aronoff MS; Durell J
    J Psychiatr Res; 1970 Feb; 7(3):171-83. PubMed ID: 5440858
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical criteria for classifying depressive disorders and predicting responses to pharmacotherapy: preliminary findings from studies of norepinephrine metabolism. Contributions to biochemistry.
    Schildkraut JJ
    Pharmakopsychiatr Neuropsychopharmakol; 1974 Mar; 7(2):98-107. PubMed ID: 4438430
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of lithium on norepinephrine turnover and metabolism: basic and clinical studies.
    Schildkraut JJ
    J Nerv Ment Dis; 1974 May; 158(5):348-60. PubMed ID: 4823935
    [No Abstract]   [Full Text] [Related]  

  • 16. Relative activity of metabolic pathways for norepinephrine in endogenous depression.
    Roy A; Linnoila M; Karoum F; Pickar D
    Acta Psychiatr Scand; 1986 Jun; 73(6):624-8. PubMed ID: 3751666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions.
    Schildkraut JJ; Orsulak PJ; Schatzberg AF; Gudeman JE; Cole JO; Rohde WA; LaBrie RA
    Arch Gen Psychiatry; 1978 Dec; 35(12):1427-33. PubMed ID: 727878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catecholamine metabolism of manic-depressive illness.
    Takahashi R; Nagao Y; Tsuchiya K; Takamizawa M; Kobayashi T; Toru M; Kobayashi K; Kariya T
    J Psychiatr Res; 1968 Dec; 6(3):185-99. PubMed ID: 5731854
    [No Abstract]   [Full Text] [Related]  

  • 19. [Urinary excretion of MHPG in endogenous depression. Clinico-therapeutic index].
    Roccatagliata G; Maini A; Bino G
    Minerva Psichiatr; 1981; 22(2):75-8. PubMed ID: 7266322
    [No Abstract]   [Full Text] [Related]  

  • 20. Depression: prognosis and drug treatment.
    Rose JT; Maxwell C
    Dis Nerv Syst; 1969 Mar; 30(3):186-8. PubMed ID: 4886702
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.